Skip to main content

NVST

Stock
Health Care
Medical Instruments & Supplies

Performance overview

NVST Price
Price Chart

Forward-looking statistics

Beta
1.27
Risk
40.45%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.

Company info

SectorHealth Care
IndustryMedical Instruments & Supplies
Employees7K
Market cap$3.1B

Fundamentals

Enterprise value$3.8B
Revenue$2.5B
Revenue per employee—
Profit margin-44.90%
Debt to equity51.40

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)-$6.54
Dividend per share—
Revenue per share$14.53
Avg trading volume (30 day)$42M
Avg trading volume (10 day)$41M
Put-call ratio—

Macro factor sensitivity

Growth+2.2
Credit+4.8
Liquidity-2.4
Inflation-0.9
Commodities+0.4
Interest Rates-2.1

Valuation

Dividend yield0.00%
PEG Ratio17.89
Price to sales1.38
P/E Ratio17.89
Enterprise Value to Revenue1.52
Price to book1.15

Upcoming events

Next earnings dayMay 2, 2025
Next dividend day—
Ex. dividend day—

News

NVST vs. ABT: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Products stocks have likely encountered both Envista (NVST) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?

Zacks Investment Research (June 26, 2025)
Should You Add NVST Stock to Your Portfolio Right Now?

Envista's global expansion, smart acquisitions, and strong balance sheet support growth but forex risks remain a drag.

Zacks Investment Research (June 19, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free